Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease prostate cancer
Phenotype C0020619|hypogonadism
Sentences 4
PubMedID- 26540339 : aging, hypogonadism, and pharmacological treatment of prostate cancer) is increasing [29,30].
PubMedID- 24741451 For example, kallmann and klinefelter syndromes, pituitary and hypothalamic tumors, and androgen deprivation therapy for prostate cancer can all lead to hypogonadism, and are associated with low bone mineral density (bmd) and an increased risk of fractures [7,8,9,10].
PubMedID- 22110984 It has been also shown in a small trial that hypogonadism in males with prostate cancer results in a rise in the augmentation of central arterial pressure, suggesting large artery stiffening.
PubMedID- 21276398 In men with iatrogenic hypogonadism due to prostate cancer, the risk of vertebral fractures is decreased by 62%.

Page: 1